Page last updated: 2024-09-03

efaproxiral and Benign Supratentorial Neoplasms

efaproxiral has been researched along with Benign Supratentorial Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carson, K; Gerber, M; Grossman, SA; Herman, T; Kleinberg, L; Lesser, G; O'Neill, A; Pearlman, J; Phillips, P	1

Trials

1 trial(s) available for efaproxiral and Benign Supratentorial Neoplasms

Article	Year
Survival of patients with newly diagnosed glioblastoma multiforme treated with RSR13 and radiotherapy: results of a phase II new approaches to brain tumor therapy CNS consortium safety and efficacy study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jul-15, Volume: 20, Issue:14 Topics: Adult; Aged; Aniline Compounds; Chemotherapy, Adjuvant; Confidence Intervals; Drug Administration Schedule; Female; Glioblastoma; Humans; Male; Middle Aged; Propionates; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Supratentorial Neoplasms; Survival Analysis; Treatment Outcome; United States	2002

Article

Year

Survival of patients with newly diagnosed glioblastoma multiforme treated with RSR13 and radiotherapy: results of a phase II new approaches to brain tumor therapy CNS consortium safety and efficacy study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jul-15, Volume: 20, Issue:14

Topics: Adult; Aged; Aniline Compounds; Chemotherapy, Adjuvant; Confidence Intervals; Drug Administration Schedule; Female; Glioblastoma; Humans; Male; Middle Aged; Propionates; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Supratentorial Neoplasms; Survival Analysis; Treatment Outcome; United States

2002